Background The use of ineffective and poor quality drugs endangers therapeutic treatment
and may lead to treatment failure. For desired therapeutic effect, drugs should contain the …

This research evaluated the biopharmaceutical equivalence in vitro of three brands of
glibenclamide 5-mg tablets (reference, brand name, and generic drugs) from Lima, Peru …

Background Diabetes mellitus is a metabolic disorder that poses a major global health
threat. The current diabetes mellitus uses insulin and oral hypoglycemic agents, which have …

Critical Quality Attributes (CQAs) is an important factor in Pharmaceutical development as it
determines the strength, release of the API from SDFs, and stability of a pharmaceutical …

This study compared the bioavailability and antihyperglycemic effect of 5 mg glibenclamide
tablets available in Sudan. Nine healthy subjects were given a 5 mg dose of either …

Glimepiride is an antidiabetic agent used for lowering blood glucose levels. It induces the
activity of peroxisome proliferator-activated receptor-gamma (PPAR gamma). It lowers blood …

Background Medicinal products, unlike any other consumer item, require special attention
because excessive or suboptimal use can have unintended consequences. Ultimately …

Albendazole tablets are listed by World Health Organization as essential medicines effective
for treatment for parasitic worm infections and are indeed widely used in many public …

“This is a review of the current status of drug bioequivalence studies in Peru. A bibliographic
search was conducted in PubMed (Medline database) for bioequivalence studies in Peru …

Background: The in vitro quality assessment of different brands of the same drugs is
essential in preventing substandard or counterfeit products, especially in developing …